The global GLP-1 analogues market is experiencing unprecedented growth, driven by the rising prevalence of type 2 diabetes, obesity, and associated cardiovascular disorders. Valued at US$ 51.6 bi...
The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 and is projected to reach US$ 211.8 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 13.7% during the...
The global GLP-1 analogues market is experiencing unprecedented growth, driven by the increasing prevalence of type 2 diabetes and obesity, expanding therapeutic applications, and continuous inno...
